EP3429658A1 - Einheit zum zubereiten von mindestens einer lösung von konzentraten für die hämodialyse und verfahren zur herstellung dieser lösung - Google Patents

Einheit zum zubereiten von mindestens einer lösung von konzentraten für die hämodialyse und verfahren zur herstellung dieser lösung

Info

Publication number
EP3429658A1
EP3429658A1 EP17717615.3A EP17717615A EP3429658A1 EP 3429658 A1 EP3429658 A1 EP 3429658A1 EP 17717615 A EP17717615 A EP 17717615A EP 3429658 A1 EP3429658 A1 EP 3429658A1
Authority
EP
European Patent Office
Prior art keywords
modules
raw materials
purified water
module
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17717615.3A
Other languages
English (en)
French (fr)
Inventor
Henri Gauthier
Nicolas TILATTI
Philippe Courtiade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemo Plus Sarl
Original Assignee
Hemo Plus Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemo Plus Sarl filed Critical Hemo Plus Sarl
Publication of EP3429658A1 publication Critical patent/EP3429658A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/1666Apparatus for preparing dialysates by dissolving solids
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04HBUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
    • E04H1/00Buildings or groups of buildings for dwelling or office purposes; General layout, e.g. modular co-ordination or staggered storeys
    • E04H1/005Modulation co-ordination
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04HBUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
    • E04H3/00Buildings or groups of buildings for public or similar purposes; Institutions, e.g. infirmaries or prisons
    • E04H3/08Hospitals, infirmaries, or the like; Schools; Prisons
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04HBUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
    • E04H5/00Buildings or groups of buildings for industrial or agricultural purposes
    • E04H5/02Buildings or groups of buildings for industrial purposes, e.g. for power-plants or factories
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3379Masses, volumes, levels of fluids in reservoirs, flow rates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3379Masses, volumes, levels of fluids in reservoirs, flow rates
    • A61M2205/3393Masses, volumes, levels of fluids in reservoirs, flow rates by weighing the reservoir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00Methods of manufacture, assembly or production
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00Methods of manufacture, assembly or production
    • A61M2207/10Device therefor

Definitions

  • the present invention relates to a unit for the preparation of at least one solution of concentrates for hemodialysis, said solution being composed of water-soluble solids comprising at least sodium chloride (NaCl), potassium chloride (KCl) , calcium chloride (CaCl 2), and magnesium chloride (MgCfc), comprising means for preparing said solution by successively introducing predetermined amounts of said solids into a predetermined volume of purified water, into a mixing tank, means for individually performing a dosage control of said solids introduced into said predetermined volume of purified water and means for individually performing a conformity check of the concentrate solution obtained at the end of the process.
  • NaCl sodium chloride
  • KCl potassium chloride
  • CaCl 2 calcium chloride
  • MgCfc magnesium chloride
  • NaCl sodium chloride
  • KCl potassium chloride
  • CaCb calcium chloride
  • MgC magnesium chloride
  • Concentrate manufacturing facilities for hemodialysis are usually assembled in industrial production plants arranged to produce large volumes of products which will then have to be stored, packaged and distributed to the treatment centers.
  • These approaches are complicated and costly and involve manipulation with health and / or medical risks, particularly because of a complex management of the packaging, related to the specific needs of the various treatment centers, transport and real-time supply of said care centers.
  • the present invention proposes to provide a unit for producing concentrates for hemodialysis, whose structure is modular, the mode of operation, namely the product manufacturing process is identical regardless of the unit, so that that the construction of the units is the same, the manufacturing process of the products, as well as all the procedures of preparation, management of the components, all the operations of maintenance and all the security steps are identical, in order to guarantee the quality of the products manufactured, an optimized production cost and a security of supply of treatment centers by hemodialysis.
  • the unit for preparing at least one hemodialysis concentrate solution characterized in that it comprises the following modules:
  • a sampling module for taking a sample of each of said raw materials to be dissolved in said volume of purified water
  • a weighing module for determining the quantity by weight of said raw materials to be introduced into said predetermined volume of purified water
  • a conditioning module of said solution obtained concentrates for hemodialysis comprises first analysis means for performing, during a first intermediate step of said analysis phase of each of said samples of raw materials, a quality control which consists in checking the conformity samples with the theoretical quality defined by at least one certificate attesting the nature and composition of the materials concerned, as well as compliance with the regulatory texts in force.
  • it also comprises second analysis means for performing, during a second intermediate step of said analysis phase of each of said raw material samples, a purity check which consists of determining the mass. actual of each of said raw materials which corresponds to the mass of the pure active ingredient contained in these raw materials according to their respective purity.
  • said means for connecting the modules with said central purification equipment comprises an air duct network arranged in a sealed space disposed above a "false ceiling" reserved in its upper part of each of said modules, said a duct network comprising, for each of said modules, at least one inlet orifice and at least one outlet orifice, each of said inlet and outlet ports being equipped with a coupling valve to ensure interconnection of at least one said conduits dudrt duct network.
  • it comprises a central water treatment equipment which supplies at least a portion of said modules, means for distributing the treated water in each of said respective modules, means for collecting the wastewater in each of said respective modules and means for connecting the modules with said central water treatment equipment and means for interconnecting the modules with each other and / or with said central water treatment equipment.
  • the method according to the invention is characterized in that it comprises the following phases:
  • a sampling phase for taking a sample of each of said raw materials to be dissolved in said volume of purified water
  • a weighing phase for determining the quantity by weight of said raw materials to be introduced into said predetermined volume of purified water
  • the analysis phase of each of said samples of raw materials to control their quality comprises a first intermediate step which consists in verifying the conformity of the samples with the theoretical quality defined by at least one certificate attesting the nature of the samples. and the composition of the subject matter.
  • the analysis phase of each of said samples of raw materials to control their quality preferably comprises a second intermediate step comprising measuring the purity of the raw materials, which consists in determining the actual mass of each of said raw materials which corresponds to the mass. pure active ingredient contained in these raw materials according to their respective purity.
  • Said phase of preparation of the solution for introducing and dissolving said quantity by weight of said raw materials in said predetermined volume of purified water advantageously comprises a first intermediate step during which the quantity by weight of said mixture tank is introduced into said mixing tank; raw materials needed to make said solution of concentrates for hemodialysis, said mixing vessel initially containing a fraction of said predetermined volume of purified water.
  • Said fraction of said predetermined volume of purified water is advantageously at least approximately between 50 and 80% of said predetermined volume, and preferably close to two-thirds of said predetermined volume.
  • phase of preparing the solution for introducing and dissolving said quantity by weight of said raw materials into said predetermined volume of purified water may comprise a second intermediate step during which the mixing tank is added to the solution obtained following said first step, the balance of said predetermined volume of purified water.
  • said phase of conditioning said solution obtained from concentrates for hemodialysis consists in transferring, during a first intermediate step, in at least one storage tank said solution obtained concentrates for hemodialysis.
  • said phase of conditioning said solution obtained concentrates for hemodialysis consists in conditioning, during a second intermediate step, said solution obtained concentrates for hemodialysis, in containers arranged to provide food a dialysis generator.
  • the process steps and the intermediate steps are carried out in dedicated modules which are interconnected for central management of the ambient air flows circulating through said modules, flows of the liquids entering and leaving the different modules, pressurized gas flows, electrical energy flows used by the equipment of said modules and circulatory flows of the speakers and components used during the process, during the course of said process phases and intermediate steps.
  • an upper zone of each of said modules concerned is advantageously housed in an isolated space containing circulation paths of an incoming atmosphere and an outgoing atmosphere communicating respectively with a central module for air treatment.
  • FIG. 1 is a schematic overall view showing the production unit for concentrates for hemodialysis manufactured according to the method of the invention
  • - Figure 2 is a detailed view of the weighing module which illustrates the equipment to ensure a preliminary phase in the manufacture of concentrates for hemodialysis according to the
  • FIG. 3 is a detailed view of the preparation module illustrating the equipment used to ensure the actual manufacture of concentrates for hemodialysis according to the method of the invention.
  • FIG. 4 is a detailed view of the storage module which illustrates the equipment making it possible to store the concentrates for hemodialysis obtained according to the method of the invention
  • FIG. 5 is a detailed view of the conditioning module of concentrates for hemodialysis obtained.
  • FIG. 6 is a detailed view of the sampling module of raw materials with a view to checking their validation
  • FIG. 7 is a detailed view of the chemical, physical and bacteriological laboratory module intended to control the quality and purity of the raw materials used in the composition of the hemodialysis concentrates obtained according to the method of the invention, as well as the quality and conformity of the finished or concentrated products for hemodialysis
  • FIG. 4 is a detailed view of the storage module which illustrates the equipment making it possible to store the concentrates for hemodialysis obtained according to the method of the invention
  • FIG. 5 is a detailed view of the conditioning module of concentrates for hemodialysis obtained. according to the method of the invention
  • FIG. 6 is a detailed view of the sampling module of raw materials with a view to checking
  • FIG. 8 is a detailed view of a water treatment module which forms part of the composition of hemodialysis concentrates obtained according to the method of the invention and which is used during the phases of this process
  • FIG. 9 is a detailed view of a utilities module which is arranged to process, prepare and package flows and / or energies used in the process of the invention
  • FIG. 10 is a detailed view of a module of washing which is arranged to control the inputs of operating personnel and equipment and products used during the process of the invention
  • Figure 11 is a detailed view of a neutralization module (NEUT) effluents obtained in the part of the process of the invention.
  • NEUT neutralization module
  • the unit 10 for the production of concentrates for hemodialysis (CH) represented consists of a set of modules, detailed in FIGS. 2 to 9, which are all coupled and interconnected. such that the functions of the respective modules and the equipment they contain can be activated according to the phases of the method according to the invention.
  • modules there is a first group 1, modules called production modules (PROD) whose function is to manufacture the (CH) from raw materials (MA) soluble in water.
  • PROD production modules
  • PESE weighing module
  • a second module called preparation module has the function of mixing the solid raw materials in purified water to produce said concentrates.
  • a third module called storage module has the function of collecting in at least one storage tank, the concentrates produced by the module (PREP) and to contain them momentarily at the end of their manufacture.
  • a fourth module called conditioning module has the function of conditioning the concentrates in containers of smaller volume, in particular having a sufficient volume to allow, after an appropriate final dilution, to perform a treatment session by hemodialysis. 'a patient. This module could be limited to a packaging machine, without constituting alone or fill a complex module with multiple functions.
  • production modules or the specific modules and machines arranged in addition to the modules, are designed to start initially with the collection of the appropriate raw materials (MA) and lead to the finished products (CH). , ready for distribution after having undergone all the verifications, all the validations and all the safety and qualitative interventions required for a product for medical use as sensitive as the concentrates for hemodialysis.
  • modules called control modules whose function is to ensure both the control of raw materials (MA), and that of finished products, in this case concentrates (CH) manufactured.
  • a first module called the sampling module (PREL) is part of this second group, and it consists in taking samples of raw materials (MA) in order to verify that they comply with the data declared by the suppliers and with the regulatory texts. force, and with the specificity sheets.
  • a second module called laboratory module (L.A.B.O) belongs to this second group, and consists of performing chemical, physical and bacteriological analyzes of raw material samples (MA) isolated beforehand in the module (P.R.E.L).
  • the said modules that make up unit 10 there will be a third group
  • FLUX utility modules
  • the first module of said third group 3 is a so-called water treatment module or module (TH2.0) whose function is to prepare the purified water in which the raw materials (MA) will be dissolved in order to produce the concentrates (CH). It may for example comprise a reverse osmosis filtration machine or the like in order to eliminate any solid mineral residues and to neutralize the organic and / or bacteriological residues.
  • the second module of this third group 3 is called utilities module (UTIL) which can include a group of compressed air that supplies all the units of the unit 10 requiring compressed air, a water generator hot, arranged to supply hot water at the required temperature to all the relevant stations of the unit 10, a hot water storage tank produced and an electric power distributor that ensures the power supply of all Workstations in the different modules of unit 10.
  • UTIL utilities module
  • a third module of this third group of modules 3, is called washing module (LAVA) which is organized to control and manage the input flows of stakeholders through controlled passage systems called locks and washing equipment.
  • LAVA washing module
  • a fourth module, of this third group 3, which is said air handling module (TAIR) is designed to ensure in particular the dehumidification and purification of the air flowing in the various modules.
  • TAIR air handling module
  • a fourth group 4, called (EFFL) comprises one or more modules called neutralization module (NEUT) effluents whose purpose is to treat and if necessary to neutralize the effluents from production and ancillary treatments, in order to be able to reject them safely and legally after the production of concentrates for hemodialysis (CH).
  • NEUT neutralization module
  • the production of concentrates for hemodialysis begins in the first group 1, modules called production modules (PROD) and more specifically by the weighing module (PESE) illustrated in Figure 2.
  • This module 31 is equipped with weighing means 32, arranged under a fume hood 33.
  • a zone 34 makes it possible to manage the secure entry of the personnel, a zone 35 makes it possible to weigh the raw materials (MA) and a zone 36 makes it possible to condition the weighed products.
  • the weighing module comprises integrated ventilation means which are arranged laterally and consist of two channels 37a and 37b which run along the side walls of the module.
  • channels 37a and 37b are housed in the upper part of the module 31, for example in a space separated from the interior of the module by a false ceiling or the like.
  • the preparation module 41 (PREP), illustrated in FIG. 3, which aims to dissolve the raw materials (MA) previously dosed into the water. 'purified water.
  • a preparation tank 42 or mixing tank containing a fraction of the volume intended to manufacture the expected volume of concentrates for hemodialysis (CH), in a first step, and then after mixing this mixture , to complete the volume of purified water to achieve the objectives set.
  • the raw materials (MA) are brought from a zone 43 into a zone 44 in which the purified water is fed into the preparation tank 41.
  • the preparation module 41 (PR) EP) comprises integrated ventilation means which are arranged laterally and consist of two channels 47a and 47b which run along the side walls of the module. These channels are in communication with the entire air distribution and ventilation circuit comprise means of intercommunication with the other channels having the same functions of the other modules of the unit 10.
  • the storage module 51 (MSTO), represented by FIG. is intended to store the concentrates for hemodialysis (CH) produced, for example in three storage tanks 52, 53 and 54.
  • the storage of the products in these tanks is temporary and it is used to feed containers or packaging intended directly to the customer. use in patients at the time of treatment with hemodialysis.
  • the storage module 51 is equipped with two channels 57a and 57b which run along the side walls of the module and which are in communication with the whole of the ventilation circuit and of air distribution comprise means of intercommunication with the other channels having the same functions of the other modules of the unit 10.
  • the conditioning module 61 aims to distribute the concentrates for hemodialysis (CH) in containers 62 suitable for the treatment of patients.
  • the concentrates (CH) produced are initially diluted, for example of the order of ten times to be consumed directly by the dialysis machines.
  • the conditioning module 61 (COND) is equipped with two channels 67a and 67b which run along the side walls of the module and which are in communication with the whole of the ventilation and air distribution circuit comprising means of intercommunication with the other channels having the same functions of other modules of unit 10.
  • the unit 10 comprises a second group 2 of so-called control modules (CONT), in particular a first module 71, called the sampling module (PREL), represented by FIG. 6, which serves to take samples of materials (MA), in order to check whether they are
  • the module 71 comprises sampling means 72 for verifications. It is also equipped with two channels 77a and 77b which run along the side walls of the module and which are in communication with the entire air distribution and ventilation circuit comprise means
  • the 10 of this module also comprises an entry lock 73 for controlling the penetration of the personnel and a hood 74 for controlling the flow of air flowing in. the module and in particular in the zone 75 where the samples are taken.
  • a second module 81 is part of this second group of control modules (CONT) and is assigned to chemical, physical and bacteriological analyzes of the raw material samples (MA). previously isolated in module 0 (PREL) and finished products. It comprises three separate zones disposed within the module 81, a bacteriological analysis zone 82, a physical analysis zone and a chemical analysis zone 84 which are carried out on the raw materials (MA) or on various products used in the process, such as purified water, circulating air or effluents. He is also
  • the first module of said third group 3, is a module 91 called water treatment or module (TH2.0), represented by FIG. 8, whose function is to prepare the purified water in which will be dissolved materials first (MA) to make concentrates (CH) and to manage cooled water and hot water in two separate loops. It may for example comprise a reverse osmosis filtration machine 92 or the like. It comprises a tank 93 of purified water storage, to allow to have a water reserve permanently for use in the production phase.
  • the module 91 may contain a softener 94, a refrigeration exchanger 95 and a heat exchanger 96 for managing independent circuits of hot water and chilled water.
  • FIG. 9 illustrates the utilities module which is arranged to process, prepare and package flows and / or energies used in the process.
  • the module 101 may comprise in particular an electrical management unit 102, a softened water tank 103, a hot water production unit 104 and a compressed air generation unit 105.
  • FIG. 10 illustrates the washing unit (LAVA) 111 which is provided with a laundry 112 for cleaning everything that enters the processing circuit of the unit 10.
  • Inlet locks 113 are provided to secure and control all incoming equipment as well as operational staff.
  • FIG. 11 illustrates the tributary neutralization module called N.E.U.T which is part of group 4 (E.F.F.L), and whose purpose is to purge and neutralize the effluents before evacuating them.
  • the modular construction of this unit has several advantages related in particular to the constructive concept and distribution of all operational components that are organized according to immutable validated rules from one unit to another. Centralized central management of all flows and energies is a guarantee of security by providing an overview and widespread maintenance. The costs of an installation are predictable and independent of local parameters. The training of the operational staff can be carried out in any unit and the personnel can be interchanged from one unit to another, if necessary without requiring specific training.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Ventilation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP17717615.3A 2016-03-18 2017-03-17 Einheit zum zubereiten von mindestens einer lösung von konzentraten für die hämodialyse und verfahren zur herstellung dieser lösung Pending EP3429658A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH00377/16A CH712274B1 (fr) 2016-03-18 2016-03-18 Unité pour la préparation d'au moins une solution de concentrés pour hémodialyse et procédé de préparation de cette solution.
PCT/CH2017/000029 WO2017156643A1 (fr) 2016-03-18 2017-03-17 Unite pour la preparation d'au moins une solution de concentres pour hemodialyse et procede de preparation de cette solution

Publications (1)

Publication Number Publication Date
EP3429658A1 true EP3429658A1 (de) 2019-01-23

Family

ID=56888866

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17717615.3A Pending EP3429658A1 (de) 2016-03-18 2017-03-17 Einheit zum zubereiten von mindestens einer lösung von konzentraten für die hämodialyse und verfahren zur herstellung dieser lösung

Country Status (11)

Country Link
US (1) US20190083691A1 (de)
EP (1) EP3429658A1 (de)
JP (1) JP6964887B2 (de)
KR (1) KR20180135903A (de)
CN (1) CN109069720B (de)
CH (1) CH712274B1 (de)
MA (1) MA43323A1 (de)
MX (1) MX2018011321A (de)
TN (1) TN2018000305A1 (de)
WO (1) WO2017156643A1 (de)
ZA (1) ZA201806859B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018121671B4 (de) * 2018-09-05 2021-01-07 Fresenius Medical Care Deutschland Gmbh Medienversorgungseinrichtung zur Versorgung eines medizinischen Behandlungsgeräts
US11795682B2 (en) * 2019-06-03 2023-10-24 Jgc Corporation Plant construction module, plant, manufacturing method for plant construction module, and plant construction method
CH716516A1 (fr) * 2019-08-22 2021-02-26 Mpi Int Sa Procédé de préparation d'au moins une solution injectable en poche, unité pour la préparation de ladite solution injectable et poche contenant ladite solution injectable.
CH716733A1 (fr) * 2019-10-29 2021-04-30 Mpi Int Sa Procédé de préparation d'au moins une solution injectable en ampoule, unité pour la préparation de ladite solution injectable et ampoule contenant ladite solution injectable.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195636B2 (ja) * 1992-03-19 2001-08-06 ガンブロ株式会社 血液透析液用原液の調剤法及び血液透析液用原液調剤用ソフトバッグ
ES2069499B1 (es) * 1993-09-30 1996-01-01 Sapena Juan Pinol Procedimiento de envasado de compuestos y concentrados para utilizar en el tratamiento de la dialisis y hemodialisis.
JP3589489B2 (ja) * 1994-09-12 2004-11-17 サイテック株式会社 透析液の調剤に利用する薬剤と溶解調剤方法
EG24303A (en) * 1998-10-20 2009-01-12 Advanced Renal Technologies Buffered compositions for dialysis
AU2008260230B2 (en) * 2007-05-29 2013-09-19 Fresenius Medical Care Holdings, Inc. Solutions, dialysates, and related methods
CA2750852A1 (en) * 2008-12-23 2010-07-01 Xoma, Technology Ltd. Flexible manufacturing system
CN102038978A (zh) * 2009-10-20 2011-05-04 上海和亭商贸有限公司 一种血液透析浓缩物
WO2011125758A1 (ja) * 2010-03-31 2011-10-13 富田製薬株式会社 透析組成物、血液透析システムおよび血液透析器
JP5918059B2 (ja) * 2011-07-29 2016-05-18 日機装株式会社 透析用剤および透析用剤の製造方法
DE102012002372B4 (de) * 2012-02-08 2013-11-21 Fresenius Medical Care Deutschland Gmbh Konzentrat für eine Dialysierflüssigkeit und daraus hergestellte Dialysierflüssigkeit
JP5517321B1 (ja) * 2013-10-02 2014-06-11 富田製薬株式会社 二酢酸アルカリ金属塩を含む固形透析用a剤、及びそれを用いた2剤型の低酢酸透析用剤

Also Published As

Publication number Publication date
CH712274B1 (fr) 2020-06-30
WO2017156643A1 (fr) 2017-09-21
CH712274A1 (fr) 2017-09-29
CN109069720A (zh) 2018-12-21
JP2019510560A (ja) 2019-04-18
CN109069720B (zh) 2023-02-03
TN2018000305A1 (en) 2020-01-16
MX2018011321A (es) 2019-05-27
US20190083691A1 (en) 2019-03-21
MA43323A1 (fr) 2019-10-31
ZA201806859B (en) 2019-07-31
JP6964887B2 (ja) 2021-11-10
KR20180135903A (ko) 2018-12-21

Similar Documents

Publication Publication Date Title
WO2017156643A1 (fr) Unite pour la preparation d'au moins une solution de concentres pour hemodialyse et procede de preparation de cette solution
CN103313739B (zh) 透析供应***
CN102112400A (zh) 复合过滤和去矿质设备
US10064986B2 (en) Recharger for recharging zirconium phosphate and zirconium oxide modules
JP2012016618A5 (de)
EP3482021A1 (de) Eigenständige behandlungseinheit für hämodialysebehandlungen
WO2016191039A1 (en) Recharger for recharging zirconium phosphate and zirconium oxide modules
CN102603093A (zh) 一种净水厂设备
CN107085043A (zh) 分析物浓缩器***和使用方法
CN101690824A (zh) 湿热蒸汽灭菌柜的在线灭菌装置
CN109589467A (zh) 腹膜透析液纯度控制***
WO2018127986A1 (ja) リアルタイム大容量水素水生成器
CN108383074A (zh) 联动模块化再装填***
WO2021081678A1 (fr) Unité pour la préparation d'une solution injectable en ampoule et ampoule contenant ladite solution injectable
SA517382060B1 (ar) رأس توزيع معياري لجسم مبيت غشاء
WO2021030919A1 (fr) Unité pour la préparation d'une solution injectable en poche et poche contenant ladite solution injectable.
US20220126006A1 (en) Peritoneal diaylsis system and cassettes therefor
CN205556328U (zh) 一种医疗用水水处理***
CN106163633A (zh) 用于水过滤的***和方法
JP7447078B2 (ja) 中央制御された複数患者透析処置システムおよびその使用法
OA18871A (en) Unit for preparing at least one solution of concentrates for haemodialysis and method for preparing said solution
CN106726576B (zh) 一种混悬剂配制输送***
EP2783414B1 (de) Verfahren und vorrichtungen zur remineralisierung und/oder zur korrektur des ph-wertes von in einem flugzeug erzeugtem wasser
JPH03261480A (ja) 透析装置
JP6095887B2 (ja) 液体管理システム

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181018

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HEMO PLUS SARL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220523

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN